Related Experiment Video
Updated: Nov 14, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
3.1K
SARS-CoV-2 infection with pneumonia and encephalitis
Muhammad Hassan1, Fibhaa Syed2, Haris Majid Rajput1
1Department of Neurology, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan.
Brain Hemorrhages
|March 9, 2021
Summary
This case study highlights a fatal COVID-19 infection with severe respiratory complications. Neurological manifestations in SARS-CoV-2 patients require further investigation due to limited data.
Area of Science:
- Neurology
- Infectious Diseases
- Critical Care Medicine
Background:
- The severe acute respiratory virus (SARS-CoV-2) pandemic primarily presents with respiratory symptoms, including pneumonia and acute respiratory distress syndrome (ARDS).
- Limited data exists regarding the specific neurological manifestations associated with COVID-19 infections.
- Previous studies indicate that less than 30% of the population reported neurological symptoms like headache and delirium.
Observation:
- This case study focuses on a patient diagnosed with COVID-19.
- The patient experienced severe respiratory complications during hospitalization.
- The patient ultimately succumbed to the illness.
Findings:
- The neurotropism of SARS-CoV-2 remains a subject of debate and uncertainty.
- This case underscores the potential for severe outcomes in COVID-19 patients.
Implications:
- Further research is crucial to understand the neurological impact of SARS-CoV-2.
- Investigating COVID-19's neurotropism is essential for comprehensive patient management.
- This case highlights the critical need for vigilance regarding severe COVID-19 presentations.
Related Concept Videos
01:29Pneumonia II: Pathophysiology
1.6K
The pathophysiology of pneumonia involves the following steps:
1.6K
01:30Pneumonia III: Complications and Assessment
573
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
573
01:30Pneumonia I: Introduction
490
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
490
01:21Acute Respiratory Failure-II
657
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
657
01:28Pneumonia IV: Management
566
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
566
01:03Rous Sarcoma Virus (RSV) and Cancer
5.8K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.8K